MATURE B-CELL MALIGNANCIES
Clinical trials for MATURE B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for MATURE B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests an experimental drug called BGB-11417 (sonrotoclax) in people with certain B-cell blood cancers that have come back or not responded to prior treatment. The main goals are to find the safest dose and to check for side effects when given alone or combined with oth…
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New targeted drug shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests a new drug called BGB-11417 in about 64 adults with certain B-cell blood cancers (like lymphoma) that have come back or not responded to prior treatments. The main goals are to find the safest dose and check for side effects. Researchers will also wat…
Matched conditions: MATURE B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 12:02 UTC